Author: Karl

GN Hearing to Delay Key 2021 Product Launches, Restructure R&D

GN Hearing, the parent company of ReSound and Beltone, announced in a profit warning that it is experiencing delays in product development deliverables leading to postponement of key product launches planned for H2 2021. The company has decided to initiate a transformation of R&D with the objective to increase quality, predictability of delivery times, and R&D efficiency.

Read More

Eargo Stock Price Reels After News of DOJ Investigation

Eargo disclosed in a Securities and Exchange Commission filing that “it is the target of a criminal investigation by the Department of Justice related to insurance reimbursement claims the company has submitted on behalf of its customers covered by federal employee health plans.” Its stock price was as high as $76.75 in mid-February, but opened today at $6.60.

Read More

COVID-19 and Its Possible Impact on the Audiovestibular System

Research into the association between COVID-19 and hearing-related symptoms is still in the early phases. Fortunately, our knowledge of the audiovestibular system continues to grow alongside with our understanding of COVID-19. Authors Matthew Kelley, AuD, and Sugata Bhattacharjee, AuD, provide a brief review of research on Covid-19 and its impact on the ear.

Read More

Neuromod Appoints Diarmuid Flavin as COO

The Dublin-based tinnitus device maker has hired Diarmuid Flavin as its new COO, after announcing last week the establishment of its US headquarters in Oakbrook, Ill, and the appointment of several well-known hearing industry experts.

Read More